Related Experiment Video
Updated: Nov 3, 2025

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
Iván Ferraz-Amaro1, Alfonso Corrales2,3, Juan Carlos Quevedo-Abeledo4
1Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. iferrazamaro@hotmail.com.
Insights
Cardiovascular risk in rheumatoid arthritis (RA) patients is often underestimated by standard charts. Disease activity, assessed via carotid ultrasound, significantly reclassifies RA patients to a very high cardiovascular risk category.
Area of Science:
- Rheumatology
- Cardiology
- Medical Imaging
Background:
- Systematic Coronary Risk Assessment (SCORE) algorithms often underestimate cardiovascular (CV) risk in rheumatoid arthritis (RA) patients.
- Carotid ultrasound is a valuable tool for identifying high CV risk in RA patients.
Purpose of the Study:
- To determine if specific RA disease features influence CV risk reclassification using SCORE charts and carotid ultrasound.
- To identify predictors of CV risk reclassification in RA patients.
Main Methods:
- 1279 RA patients without prior CV events, diabetes, or chronic kidney disease were analyzed.
- Disease characteristics, CV comorbidity, SCORE, and carotid plaque presence were assessed.
- Multivariable regression and predictive modeling were used to evaluate disease features' association with risk reclassification.
Main Results:
- Carotid ultrasound revealed carotid plaque in 54% of patients, reclassifying them to very high CV risk.
- Disease activity was significantly associated with CV risk reclassification.
- A predictive model including dyslipidemia, hypertension, age >54, and DAS28-ESR ≥2.6 showed high discrimination for reclassification.
Conclusions:
- Over half of RA patients are reclassified to very high CV risk by carotid ultrasound.
- Disease activity is an independent predictor of this CV risk reclassification in RA.
Background:
Previous studies have shown that risk chart algorithms, such as the Systematic Coronary Risk Assessment (SCORE), often underestimate the actual cardiovascular (CV) risk of patients with rheumatoid arthritis (RA). In contrast, carotid ultrasound was found to be useful to identify RA patients at high CV. In the present study, we aimed to determine if specific disease features influence the CV risk reclassification of RA patients assessed by SCORE risk charts and carotid ultrasound.
Methods:
1279 RA patients without previous CV events, diabetes, or chronic kidney disease were studied. Disease characteristics including disease activity scores, CV comorbidity, SCORE calculation, and the presence of carotid plaque by carotid ultrasound were assessed. A multivariable regression analysis was performed to evaluate if the reclassification into very high CV risk category was independently associated with specific features of the disease including disease activity. Additionally, a prediction model for reclassification was constructed in RA patients.
Results:
After carotid ultrasound assessments, 54% of the patients had carotid plaque and consequently fulfilled definition for very high CV risk. Disease activity was statistically significantly associated with reclassification after fully multivariable analysis. A predictive model containing the presence of dyslipidemia and hypertension, an age exceeding 54 years, and a DAS28-ESR score equal or higher than 2.6 yielded the highest discrimination for reclassification.
Conclusion:
Reclassification into very high CV risk after carotid ultrasound assessment occurs in more than the half of patients with RA. This reclassification can be independently explained by the activity of the disease.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction

